Diebold Nixdorf, Incorporated

Fundamentals5.0
Price Action4.0
News Sentiment0.0
AI Rating
5.0

Key Drivers

  • Steady Revenue
  • Leverage Pressure
  • Weak Cash Flow

AI
AI Summary

5.0

DBD is now a margin-and-execution story rather than a pure turnaround: profitability and order wins are improving, but the stock likely needs clear proof that banking/retail/service deployments can convert into sustained revenue growth and cash generation before a rerating is justified, given leverage and cash-flow volatility.

MarginExpansion
ExecutionRisk
Leverage‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

5.0

Key Financial Insights:

  • Steady Revenue
  • Leverage Pressure
  • Weak Cash Flow

DBD offers steady revenue and decent full-year cash generation, but thin profitability, rising leverage, weak recent cash flow, and heavy intangibles make the risk-reward balanced to cautious.

MixedOutlook
LeverageRisk

Price Behavior

4.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Failed breakout
  • Base holding
  • Mid-70s barrier

DBD has shifted from a strong rally into a sharp correction over the last month, with $71-$72 holding as support for now but $75-$78 still the key resistance to reclaim before any real trend reversal.

oversold
correction
Support Level: $71-$72
Resistance Level: $75-$78

Fast drop from $90.75 to $73.06 shows a sharp oversold correction

Sentiment & News

0.0

Key News Insights:

  • Q2 beat
  • New banking wins
  • Analyst optimism

Diebold Nixdorf is showing improving operating momentum, with stronger Q2 results, bullish analyst sentiment, and new customer wins helping offset near-term stock volatility.

turnaround
momentum

The news flow points to a constructive setup for DBD, with execution gains and customer traction likely supporting sentiment and the stock over time